NICE EVA initial draft guidance: Artificial intelligence (AI) technologies for assessing and triaging skin lesions within the urgent suspected skin cancer pathway
We have seen the initial draft guidance and continue to work with NICE as it is finalised. At this stage, the guidance is still in draft and a third committee meeting has been set up to discuss the findings as a result of a number of stakeholders having concerns about the analysis to date.
While we work through the NICE EVA process, NHSE has been very clear to us that they want us to continue to deploy our technology to support dermatology departments across England.
Finally, we note that this evaluation doesn’t include the most recent independent evaluation referenced on the NHSE blog here.